期刊文献+

利尿剂对高血压大鼠细胞色素P450表氧化酶及血管紧张素Ⅱ1型受体基因表达的影响 被引量:11

Effects of thiazide diuretics on expression of cytochrome P450 epoxgenase and angiotensin Ⅱ receptor type 1 in spontaneously hypertensive rats
原文传递
导出
摘要 目的 噻嗪类利尿剂是广泛使用的降血压药物 ,然而其降血压机理仍然不完全清楚。本研究观察了氢氯噻嗪和吲哒帕胺对自发性高血压大鼠 (SHR)细胞色素P4 5 0 (CYP)表氧化酶 2C11及血管紧张素Ⅱ 1型受体 (AT1)基因表达的影响 ,以探讨其降低血压的分子机制。方法 成年雄性SHR随机分为三组 ,分别每日经胃管给予氢氯噻嗪 (10mg/kg)、吲哒帕胺 (0 6 2 5mg/kg)和等量去离子水灌胃 ,并测量血压和 2 4h尿量。 4周后 ,检测主要脏器的CYP表氧化酶 2C11和AT1表达情况及形态学变化。结果 氢氯噻嗪和吲哒帕胺用药 1周后动物血压降低 ,4周时降压幅度达到非常显著水平 ,与对照组比较P <0 0 1。同时在mRNA和蛋白质水平上调肾脏、心脏和主动脉中CYP表氧化酶 2C11和下调AT1基因表达 ;胶原染色显示 ,两种药物均能显著减少心肌胶原沉积 ,减轻高血压所致的肾脏损害。结论 噻嗪类利尿剂氢氯噻嗪和吲哒帕胺可能通过上调CYP表氧化酶及下调AT1降低血压和保护器官。 Objective To investigate the effects of hydrochlorothiazide (HCTZ) and indapamide on gene expression of cytochrome p450 (CYP) epoxgenase 2C11 and angiotensin Ⅱ receptor type 1 (AT 1) and to explore their molecular antihypertensive mechanisms. Methods Spontaneous hypertensive rats (SHR) were divided randomly into three groups and administered orally once a day with HCTZ (10 mg/kg), indapamide (0.625 mg/kg) and vehicle, respectively. Then body weight, blood pressure and 24 h urine volume were observed. All animals were sacrificed at 4 weeks after treatment. Morphological change and levels of gene expression of CYP2C11 and AT 1 were determined in major organs (heart, liver, kidneys and aorta). Results Both HCTZ and indapamide can effectively reduce blood pressure in SHRs, and also, up-regulate the gene expression of CYP 2C11 at mRNA and protein levels and down-regulate AT 1, so that attenuate damages of heart and kidneys induced by hypertension. Conclusion Thiazide diuretics can reduce elevated blood pressure and prevent organ damage through up-regulating the gene expression of CYP epoxgenase and down-regulating AT 1.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2004年第4期308-312,共5页 Chinese Journal of Cardiology
基金 国家自然科学基金资助项目 ( 3 9870 3 0 7)
关键词 利尿剂 高血压 大鼠 细胞色素 P450表氧化酶 血管紧张素 Ⅱ1型受体 基因表达 Diuretics Cytochrome P-450 Receptors,angiotensin
  • 相关文献

参考文献14

  • 1Chobanian AV, Bakris GL, Black HB, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA, 2003,289:2560-2573.
  • 2The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Atihypertensive and Lipid
  • 3Pickkers P, Garcha RS, Schachter M. Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension, 1999,33:1043-1048.
  • 4Pickkers P, Hughes AD. Relaxation and decrease in [Ca2+] I by hydrochlorothiazide in guinea-pig isolated mesenteric arteries. Br J Pharmacol, 1995,114:703-707.
  • 5van Brummelen P, Man in′t Veld AJ, Schalekamp MA. Haemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther, 1980,27:328-336.
  • 6Campbell DB, Brackman F. Cardiovascular protective properties of indapamide. Am J Cardiol, 1990, 65: 11H-27H.
  • 7Maier KG, Henderson L, Narayanan J, et al. Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol, 2000,279:H863-871.
  • 8Imig JD, Zhao X, Capdevila JH. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin Ⅱ hypertension. Hypertension, 2002,39:690-694.
  • 9Campbell WB, Harder DR. Prologue: EDHF-what is it? Am J Physiol Heart Circ Physiol, 2001,280:H2413-H2416.
  • 10Campbell WB, Gebremedhin D, Pratt PF, et al. Identification of epoxyeicosatrienioc acids as endothelium-derived hyperpolarizing factors. Circ Res, 1996,78:415-423.

二级参考文献13

  • 1WANG Hong, LIN Li, LU Zaiying and WANG Daowen(Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China).Up-regulation of endothelial nitric oxide synthase by cytochrome P450 arachidonic acid epoxygenase BM_3F87V[J].Progress in Natural Science:Materials International,2002,12(8):598-602. 被引量:2
  • 2[1]Vallance P,et al.Effect of endothelium-derived nitric oxide on pe-ripherial arteriolar tone in man.Lancet,1989,21:997
  • 3[2]Cannon R O.Role of nitric oxide in cardiovascular disease:Focus on the endothelium.Clin Chem,1998,44(8Pt2):1809
  • 4[3]Cohen R A,et al.Endothelium-dependent hyperpolarization,be- yond nitric oxide and cyclic GMP.Circulation,1995,92:3337
  • 5[4]Quilley J,et al.Hyperpolarizing factors.Biochem Pharmacol,1997,54:1059
  • 6[5]Harder D R,et al.Role of cytochrome P450Moncada S enzymes and metabolitesof arachidonic acid in the control of vascular tone.J Vasc Res,1995,32:79
  • 7[6]Bauersachs J,et al.Nitric oxide attenuate the release of endotheli-um-derived hyperpolarizing factor.Circulation,1996,94:3341
  • 8[7]Ramasamy S,et al.Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid.J Lipid Res,1998,89:268
  • 9[8]Graham-Lorence S,et al.An active site substitution,F87V,con-verts cytochrome P450BM-3into a regio-and stereoselective(14S,15R)-arachidonic acidepoxygenase.J Biol Chem,1997,272(2):1127
  • 10[9]Chen J K,et al.Transfection of an active cytochrome P450arachi-donic acid epoxygenase indicates that14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epi-dermal growth factor.J Biol Chem,1999,274:4764

共引文献5

同被引文献52

引证文献11

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部